Venous Thromboembolism
From the Journals
Circulatory support for RV failure caused by pulmonary embolism
A new review highlights three mechanical circulatory support options in high-risk patients, but teamwork is key.
Feature
Dabigatran recalled over potential carcinogen
The nationwide recall is because of the detection of the nitrosamine impurity, N-nitroso-dabigatran.
From the Journals
Pulmonary embolism workup needed for any sudden onset of exertional dyspnea
Missed diagnoses may mean complicated clinical course or mortality.
Conference Coverage
Novel celery seed–derived drug may improve stroke outcomes
Patients treated with butylphthalide had fewer severe neurologic symptoms and better function 90 days after the stroke, compared with those...
Feature
UnitedHealthcare tried to deny coverage to a chronically ill patient. He fought back, exposing the insurer’s inner workings.
The college student’s medical bills were running nearly $2 million a year.
Commentary
Must-read acute care medicine articles from 2022
“When 2022 began, we started seeing some light at the end of the COVID-19 tunnel.”
Latest News
Warfarin best for thrombotic antiphospholipid syndrome?
A vitamin K antagonist such as warfarin, rather than a direct oral anticoagulant, appears to be a better treatment for patients with thrombotic...
Conference Coverage
VTE prophylaxis overused in low-risk hospitalized patients
Better attention to a risk model could help determine the most appropriate type of VTE treatment, if needed.
Conference Coverage
Obstructive sleep apnea linked to unprovoked VTE
People should be made aware of these links and try to make lifestyle changes to reduce their risk of OSA.
Latest News
VTE risk not elevated in AD patients on JAK inhibitors: Study
The labels of JAK inhibitors include a boxed warning describing an increased risk of “serious heart-related events such as heart attack or stroke...
From the Journals
Updates on treatment/prevention of VTE in cancer patients
“Because patients with cancer have a baseline increased risk of VTE, compared with patients without cancer, the combination of both COVID-19 and...